Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SWRB as cleanser and emollient for pediatric atopic dermatitis
NCT04635072Phase 1Completed
- Sponsor
- RCSI/UCD Malaysia Campus
- Start
- Sep 2020
- Primary completion
- Apr 2021
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of stabilized whole rice bran in atopic dermatitis (AD), sponsored by RCSI/UCD Malaysia Campus. Primary endpoint: SCORing Atopic Dermatitis index change at 4 weeks. Started Sep 2020; status: completed.
02
Drugs
stabilized whole rice bran
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT04635072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04635072.